Biallelic somatic and germ line CCM1 truncating mutations in a cerebral cavernous malformation lesion

被引:130
作者
Gault, J
Shenkar, R
Recksiek, P
Awad, IA
机构
[1] Univ Colorado, Hlth Sci Ctr, Dept Neurosurg, Denver, CO USA
[2] Evanston NW Healthcare, Dept Neurosurg, Evanston, IL USA
关键词
genetics; mutation; stroke; hemorrhagic; vascular malformations;
D O I
10.1161/01.STR.0000157586.20479.fd
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and Purpose - Cerebral cavernous malformations (CCMs) are focal dysmorphic blood vessel anomalies that predispose patients to hemorrhagic stroke and epilepsy. CCMs are sporadic or inherited and 3 genes (CCM1, CCM2, and CCM3) have been identified. However, the role of somatic mutation in CCM genesis has been disputed. The hypothesis that somatic mutations contribute to CCM lesion genesis is tested. Methods - Mutations were identified by analysis of polymerase chain reaction (PCR) products spanning the 16 CCM1 coding exons with denaturing high-pressure liquid chromatography (DHPLC), cloning, and sequencing. Somatic mutation was verified 3 ways in lesion DNA and RNA samples. The somatic and germ line mutations were shown to be biallelic using allele specific reverse-transcribed PCR amplification and sequence analyses. Results - A somatic 34-nucleotide deletion in CCM1 is identified in a CCM lesion along with a germ line CCM1 mutation (Q455X). The somatic mutation is not present in DNA or RNA isolated from the patient's blood. These 2 genetic hits are biallelic. Conclusions - Identification of biallelic CCM1 somatic and germ line truncating mutations strongly support the "two-hit" mechanism in this CCM lesion.
引用
收藏
页码:872 / 874
页数:3
相关论文
共 9 条
[1]   De novo lesions in familial form of cerebral cavernous malformations: Clinical and MR features in 29 non-hispanic families [J].
Awad, IA .
SURGICAL NEUROLOGY, 2000, 53 (05) :483-483
[2]   Spectrum and expression analysis of KRIT1 mutations in 121 consecutive and unrelated patients with Cerebral Cavernous Malformations [J].
Cavé-Riant, F ;
Denier, C ;
Labauge, P ;
Cécillon, M ;
Maciazek, J ;
Joutel, A ;
Couteulx, SLL ;
Tournier-Lasserve, E .
EUROPEAN JOURNAL OF HUMAN GENETICS, 2002, 10 (11) :733-740
[3]  
Gault J, 2004, NEUROSURGERY, V55, P1, DOI 10.1227/01.NEU.0000126872.23715.E5
[4]   Mutation and expression analysis of the KRIT1 gene associated with cerebral cavernous malformations (CCM1) [J].
Kehrer-Sawatzki, H ;
Wilda, M ;
Braun, VM ;
Richter, HP ;
Hameister, H .
ACTA NEUROPATHOLOGICA, 2002, 104 (03) :231-240
[5]   Appearance of new lesions in two nonfamilial cerebral cavernoma patients [J].
Labauge, P ;
Brunereau, L ;
Coubes, P ;
Clanet, M ;
Tannier, C ;
Laberge, S ;
Lévy, C .
EUROPEAN NEUROLOGY, 2001, 45 (02) :83-88
[6]  
Laberge-Le Couteulx S, 2002, ARCH OPHTHALMOL-CHIC, V120, P217
[7]   Molecular genetic investigations in the CCM1 gene in sporadic cerebral cavernomas [J].
Reich, P ;
Winkler, J ;
Straube, A ;
Steiger, HJ ;
Peraud, A .
NEUROLOGY, 2003, 60 (07) :1135-1138
[8]   Krit1 missense mutations lead to splicing errors in cerebral cavernous malformation [J].
Verlaan, DJ ;
Siegel, AM ;
Rouleau, GA .
AMERICAN JOURNAL OF HUMAN GENETICS, 2002, 70 (06) :1564-1567
[9]   Mutations in KRIT1 in familial cerebral cavernous malformations [J].
Zhang, J ;
Clatterbuck, RE ;
Rigamonti, D ;
Dietz, HC .
NEUROSURGERY, 2000, 46 (05) :1272-1277